Literature DB >> 10980977

Secretory diarrhea.

L R Schiller1.   

Abstract

Diarrhea, defined as loose stools, occurs when the intestine does not complete absorption of electrolytes and water from luminal contents. This can happen when a nonabsorbable, osmotically active substance is ingested ("osmotic diarrhea") or when electrolyte absorption is impaired ("secretory diarrhea"). Most cases of acute and chronic diarrhea are due to the latter mechanism. Secretory diarrhea can result from bacterial toxins, reduced absorptive surface area caused by disease or resection, luminal secretagogues (such as bile acids or laxatives), circulating secretagogues (such as various hormones, drugs, and poisons), and medical problems that compromise regulation of intestinal function. Evaluation of patients with secretory diarrhea must be tailored to find the likely causes of this problem. Specific and nonspecific treatment can be valuable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980977     DOI: 10.1007/s11894-999-0020-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  41 in total

Review 1.  AGA technical review on the evaluation and management of chronic diarrhea.

Authors:  K D Fine; L R Schiller
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

2.  Glucose-stimulated sodium transport by the human intestine during experimental cholera.

Authors:  L R Schiller; C A Santa Ana; J Porter; J S Fordtran
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

Review 3.  Interactions between bacterial toxins and intestinal cells.

Authors:  M R Popoff
Journal:  Toxicon       Date:  1998-04       Impact factor: 3.033

Review 4.  Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites.

Authors:  A Phalipon; P J Sansonetti
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

5.  Simple objective criteria for diagnosis of causes of acute diarrhoea on rectal biopsy.

Authors:  D Jenkins; A Goodall; B B Scott
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

Review 6.  Integrative immunophysiology in the intestinal mucosa.

Authors:  M H Perdue; D M McKay
Journal:  Am J Physiol       Date:  1994-08

7.  Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal?

Authors:  J B Marshall; R Singh; A A Diaz-Arias
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

Review 8.  The role of somatostatin analogues in the treatment of refractory diarrhoea.

Authors:  M J Farthing
Journal:  Digestion       Date:  1996       Impact factor: 3.216

Review 9.  Guanylin: a peptide regulator of epithelial transport.

Authors:  L R Forte; M G Currie
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

Review 10.  5-Hydroxytryptamine, enterotoxins, and intestinal fluid secretion.

Authors:  O Lundgren
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

View more
  5 in total

1.  Evaluating the patient with diarrhea: a case-based approach.

Authors:  Seth Sweetser
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

2.  Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea.

Authors:  Bai-Sui Feng; Shao-Heng He; Peng-Yuan Zheng; Linda Wu; Ping-Chang Yang
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

Review 3.  HIV/AIDS-related hyponatremia: an old but still serious problem.

Authors:  Zhanjun Shu; Zimeng Tian; Jinglin Chen; Jianping Ma; Aihemaiti Abudureyimu; Qianqian Qian; Li Zhuo
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

4.  Plumbagin Prevents Secretory Diarrhea by Inhibiting CaCC and CFTR Channel Activities.

Authors:  Bo Yu; Xiaojuan Zhu; Xinyu Yang; Lingling Jin; Jia Xu; Tonghui Ma; Hong Yang
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

5.  Evaluating next-generation sequencing for direct clinical diagnostics in diarrhoeal disease.

Authors:  K G Joensen; A L Ø Engsbro; O Lukjancenko; R S Kaas; O Lund; H Westh; F M Aarestrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.